Huntingtin is cleaved by caspases in the cytoplasm and translocated to the nucleus via perinuclear sites in Huntington's disease patient lymphoblasts

被引:33
作者
Sawa, A
Nagata, E
Sutcliffe, S
Dulloor, P
Cascio, MB
Ozeki, Y
Roy, S
Ross, CA
Snyder, SH
机构
[1] Johns Hopkins Univ, Dept Psychiat & Behav Sci, Sch Med, Baltimore, MD 21205 USA
[2] Johns Hopkins Univ, Dept Neurosci, Sch Med, Baltimore, MD 21205 USA
[3] Johns Hopkins Univ, Dept Neurol, Sch Med, Baltimore, MD 21205 USA
[4] Johns Hopkins Univ, Dept Pharmacol & Mol Sci, Sch Med, Baltimore, MD 21205 USA
关键词
Huntington's disease; perinuclear site; Htt; cleavage; caspase;
D O I
10.1016/j.nbd.2005.02.013
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Accumulation of mutant Huntingtin (Htt), especially the N-terminal-cleaved Htt, participates in the pathophysiology of Huntington's disease (HD). it is difficult to elucidate temporal properties of the translocation of "endogenous" Htt using autopsy HD patient brains. Thus, we examined the cell biology of "endogenous" Htt cleavage and nuclear translocation in cultured lymphoblasts of HD patients and controls. Apoptotic stimulation of lymphoblasts elicits caspase-dependent cleavage and selective nuclear translocation of N-terminal portions of Htt. Discrete clusters of the N-terminal Hit accumulate at unique perinuclear sites prior to nuclear translocation. Our findings suggest that caspase cleavage of Htt is cytoplasmic and precedes sorting to specific perinuclear sites followed by nuclear translocation in HD patient tissue. (c) 2005 Elsevier Inc. All rights reserved.
引用
收藏
页码:267 / 274
页数:8
相关论文
共 46 条
[1]   Death receptors: Signaling and modulation [J].
Ashkenazi, A ;
Dixit, VM .
SCIENCE, 1998, 281 (5381) :1305-1308
[2]   Cytochrome c binds to inositol (1,4,5) trisphosphate receptors, amplifying calcium-dependent apoptosis [J].
Boehning, D ;
Patterson, RL ;
Sedaghat, L ;
Glebova, NO ;
Kurosaki, T ;
Snyder, SH .
NATURE CELL BIOLOGY, 2003, 5 (12) :1051-1061
[3]   Aberrant interactions of transcriptional repressor proteins with the Huntington's disease gene product, huntingtin [J].
Boutell, JM ;
Thomas, P ;
Neal, JW ;
Weston, VJ ;
Duce, J ;
Harper, PS ;
Jones, AL .
HUMAN MOLECULAR GENETICS, 1999, 8 (09) :1647-1655
[4]   Truncated N-terminal fragments of huntingtin with expanded glutamine repeats form nuclear and cytoplasmic aggregates in cell culture [J].
Cooper, JK ;
Schilling, G ;
Peters, MF ;
Herring, WJ ;
Sharp, AH ;
Kaminsky, Z ;
Masone, J ;
Khan, FA ;
Delanoy, M ;
Borchelt, DR ;
Dawson, VL ;
Dawson, TM ;
Ross, CA .
HUMAN MOLECULAR GENETICS, 1998, 7 (05) :783-790
[5]   Formation of neuronal intranuclear inclusions underlies the neurological dysfunction in mice transgenic for the HD mutation [J].
Davies, SW ;
Turmaine, M ;
Cozens, BA ;
DiFiglia, M ;
Sharp, AH ;
Ross, CA ;
Scherzinger, E ;
Wanker, EE ;
Mangiarini, L ;
Bates, GP .
CELL, 1997, 90 (03) :537-548
[6]   Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain [J].
DiFiglia, M ;
Sapp, E ;
Chase, KO ;
Davies, SW ;
Bates, GP ;
Vonsattel, JP ;
Aronin, N .
SCIENCE, 1997, 277 (5334) :1990-1993
[7]   Sp1 and TAFII130 transcriptional activity disrupted in early Huntington's disease [J].
Dunah, AW ;
Jeong, H ;
Griffin, A ;
Kim, YM ;
Standaert, DG ;
Hersch, SM ;
Mouradian, MM ;
Young, AB ;
Tanese, N ;
Krainc, D .
SCIENCE, 2002, 296 (5576) :2238-2243
[8]   Calpain activation in Huntington's disease [J].
Gafni, J ;
Ellerby, LM .
JOURNAL OF NEUROSCIENCE, 2002, 22 (12) :4842-4849
[9]   Calcium-dependent cleavage of endogenous wild-type huntingtin in primary cortical neurons [J].
Goffredo, D ;
Rigamonti, D ;
Tartari, M ;
De Micheli, A ;
Verderio, C ;
Matteoli, M ;
Zuccato, C ;
Cattaneo, E .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (42) :39594-39598
[10]   Cleavage of huntingtin by apopain, a proapoptotic cysteine protease, is modulated by the polyglutamine tract [J].
Goldberg, YP ;
Nicholson, DW ;
Rasper, DM ;
Kalchman, MA ;
Koide, HB ;
Graham, RK ;
Bromm, M ;
KazemiEsfarjani, P ;
Thornberry, NA ;
Vaillancourt, JP ;
Hayden, MR .
NATURE GENETICS, 1996, 13 (04) :442-449